Lifecore Biomedical, Inc.
LFCR · NASDAQ
5/25/2025 | 5/26/2024 | 5/28/2023 | 5/29/2022 | |
|---|---|---|---|---|
| Market Cap | $234 | $171 | $238 | $291 |
| - Cash | $8 | $8 | $19 | $2 |
| + Debt | $131 | $130 | $113 | $248 |
| Enterprise Value | $357 | $293 | $332 | $537 |
| Revenue | $129 | $128 | $103 | $111 |
| % Growth | 0.5% | 24.2% | -7.2% | – |
| Gross Profit | $40 | $42 | $28 | $39 |
| % Margin | 31.3% | 32.6% | 27.1% | 35.1% |
| EBITDA | -$9 | $36 | -$33 | $13 |
| % Margin | -6.8% | 27.8% | -32.1% | 11.5% |
| Net Income | -$39 | $12 | -$100 | -$117 |
| % Margin | -30% | 9.4% | -96.4% | -104.9% |
| EPS Diluted | -1.27 | 0.33 | -3.32 | -3.97 |
| % Growth | -484.8% | 109.9% | 16.4% | – |
| Operating Cash Flow | -$0 | $0 | -$17 | -$23 |
| Capital Expenditures | -$13 | -$18 | -$21 | -$30 |
| Free Cash Flow | -$14 | -$18 | -$39 | -$53 |